IN182040B - - Google Patents

Info

Publication number
IN182040B
IN182040B IN1078CA1996A IN182040B IN 182040 B IN182040 B IN 182040B IN 1078CA1996 A IN1078CA1996 A IN 1078CA1996A IN 182040 B IN182040 B IN 182040B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Leslie George Humber
Gerald Louis Reuter
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of IN182040B publication Critical patent/IN182040B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058Chewing gums
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
IN1078CA1996 1995-06-13 1996-06-10 IN182040B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17195P 1995-06-13 1995-06-13

Publications (1)

Publication Number Publication Date
IN182040B true IN182040B (de) 1998-12-12

Family

ID=21690247

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1078CA1996 IN182040B (de) 1995-06-13 1996-06-10

Country Status (26)

Country Link
US (1) US5958445A (de)
EP (1) EP0748628A3 (de)
JP (1) JPH093071A (de)
KR (1) KR970000228A (de)
CN (1) CN1152434A (de)
AR (1) AR003435A1 (de)
AU (1) AU711853B2 (de)
BR (1) BR9602758A (de)
CA (1) CA2178686A1 (de)
CO (1) CO4700456A1 (de)
CZ (1) CZ170296A3 (de)
EA (1) EA000047B1 (de)
EE (1) EE9600067A (de)
HU (1) HUP9601635A3 (de)
IL (1) IL118636A (de)
IN (1) IN182040B (de)
MA (1) MA23907A1 (de)
NO (1) NO962491L (de)
NZ (1) NZ286791A (de)
PE (1) PE10898A1 (de)
PL (1) PL314732A1 (de)
SG (1) SG46737A1 (de)
SK (1) SK74396A3 (de)
SV (1) SV1996000051A (de)
TR (1) TR199600499A2 (de)
ZA (1) ZA964928B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0974366T3 (da) 1997-03-28 2007-01-29 Eisai Co Ltd Orale, farmaceutiske præparater med nedsat bitterhed ved maskering
CN1227001C (zh) * 1999-09-10 2005-11-16 兰贝克赛实验室有限公司 依托度酸的缓释制剂
AU7595300A (en) * 1999-09-22 2001-04-24 Akzo Nobel N.V. Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs
KR100416242B1 (ko) * 1999-12-22 2004-01-31 주식회사 삼양사 약물전달체용 생분해성 블록 공중합체의 액체 조성물 및이의 제조방법
US7727548B2 (en) 2000-03-01 2010-06-01 Eisai R&D Management Co., Ltd. Rapidly disintegrable tablet containing polyvinyl alcohol
US6514537B1 (en) 2000-06-02 2003-02-04 Cumberland Swan Holdings, Inc. Magnesium citrate solution
CN1638739A (zh) * 2000-08-18 2005-07-13 法玛西雅厄普约翰美国公司 治疗成瘾性障碍的化合物
JP2004506680A (ja) * 2000-08-18 2004-03-04 ファルマシア・コーポレーション シクロオキシゲナーゼ−2阻害剤の迅速崩壊経口製剤
SK11802003A3 (sk) * 2001-02-27 2004-06-08 Ranbaxy Laboratories Limited Rýchlo rozpustné tablety enzýmového inhibítora cyklooxygenázy-2
CA2461630A1 (en) * 2001-09-26 2003-04-03 Trang T. Le Organoleptically acceptable intraorally disintegrating compositions
WO2003055525A1 (fr) * 2001-12-25 2003-07-10 Takeda Chemical Industries, Ltd. Preparations contenant un acide
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
TWI366442B (en) 2003-07-30 2012-06-21 Novartis Ag Palatable ductile chewable veterinary composition
GB0320854D0 (en) * 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
EP1716868B1 (de) 2004-01-29 2011-11-23 Medrx Co., Ltd. Entzündungshemmendes analgetikum für die äussere anwendung
WO2005105102A1 (en) * 2004-05-04 2005-11-10 Equitech Corporation Improved nsaid composition
BRPI0602825A2 (pt) * 2006-06-23 2012-04-24 Rhodia Br Ltda formulação de pó efervescente auto-refrigerante para bebidas e uso de formulação em pó efervescente
US20090258823A1 (en) * 2006-12-08 2009-10-15 George Caroline L S Composition and methods for the prevention and treatment of gastrointestinal infections
KR20190102084A (ko) 2012-02-06 2019-09-02 메리얼 인코포레이티드 전신 작용 활성제를 포함하는 구충 경구 수의학적 조성물, 이의 방법 및 용도
EP2833867B2 (de) 2012-04-04 2023-05-10 Intervet International B.V. Weiche, kaufähige pharmazeutische produkte
WO2013169218A1 (en) * 2012-05-08 2013-11-14 Mahmut Bilgic Pharmaceutical compositions of s-etodolac

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2260148A (en) * 1939-06-19 1941-10-21 Frank H Fleer Corp Chewing gum material
GB971700A (en) * 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
US3939178A (en) * 1971-06-01 1976-02-17 American Home Products Corporation Certain pyrano [3,4-b]indoles and thiopyrano[3,4-b]indoles
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
CA1097233A (en) * 1977-07-20 1981-03-10 George K. E. Gregory Packages
US4265847A (en) * 1978-03-30 1981-05-05 Kirby Pharmaceuticals Ltd Tabletting process
US4520203A (en) * 1983-08-16 1985-05-28 American Home Products Corporation Resolution of (±)-1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid using cinchonine
US4639368A (en) * 1984-08-23 1987-01-27 Farmacon Research Corporation Chewing gum containing a medicament and taste maskers
US4879108A (en) * 1985-12-20 1989-11-07 Warner-Lambert Company Confectionery delivery system for antipyretics
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
ES2055685T3 (es) * 1986-11-14 1994-09-01 Puetter Medice Chem Pharm Procedimiento para la obtencion de un medicamento que contiene ibuprofen.
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4835186A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia
IE60311B1 (en) * 1987-09-24 1994-06-29 American Home Prod Sustained release etodolac
US4861797A (en) * 1987-10-15 1989-08-29 Oratech Pharmaceutical Development Corporation Liquid ibuprofen compositions and methods of making them
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
US4835188A (en) * 1987-12-08 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4942039A (en) * 1989-05-09 1990-07-17 Miles Inc. Effervescent analgesic antacid composition having reduced sodium content
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
US5190981A (en) * 1989-08-17 1993-03-02 Sepracor Inc. Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
DE69328838T2 (de) * 1992-03-13 2000-10-12 Sepracor Inc Antipyretische und analgetische verfahren und zusammensetzungen, die optisch reines r-etodolac enthalten
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions

Also Published As

Publication number Publication date
HUP9601635A2 (en) 1997-04-28
TR199600499A2 (tr) 1996-12-21
EP0748628A2 (de) 1996-12-18
ZA964928B (en) 1997-12-10
SG46737A1 (en) 1998-02-20
HUP9601635A3 (en) 2000-06-28
PE10898A1 (es) 1998-03-20
IL118636A (en) 2000-02-17
AU711853B2 (en) 1999-10-21
NZ286791A (en) 1998-01-26
EA199600029A3 (ru) 1997-03-31
CA2178686A1 (en) 1996-12-14
CZ170296A3 (en) 1997-04-16
EA199600029A2 (ru) 1996-12-30
AU5588096A (en) 1997-01-02
IL118636A0 (en) 1996-10-16
SV1996000051A (es) 1997-02-17
BR9602758A (pt) 1998-04-22
EE9600067A (et) 1996-12-16
MA23907A1 (fr) 1996-12-31
KR970000228A (ko) 1997-01-21
NO962491D0 (no) 1996-06-12
NO962491L (no) 1996-12-16
EP0748628A3 (de) 1997-04-23
EA000047B1 (ru) 1998-04-30
PL314732A1 (en) 1996-12-23
AR003435A1 (es) 1998-08-05
CO4700456A1 (es) 1998-12-29
SK74396A3 (en) 1997-04-09
JPH093071A (ja) 1997-01-07
US5958445A (en) 1999-09-28
HU9601635D0 (en) 1996-08-28
CN1152434A (zh) 1997-06-25

Similar Documents

Publication Publication Date Title
DE69638352D1 (de)
DE69637714D1 (de)
IN187256B (de)
IN187860B (de)
IN182040B (de)
DK143195A (de)
ECSDI950232S (de)
IN187764B (de)
EP0764722A3 (de)
CH0741373H1 (de)
DK0727898T3 (de)
FR2729352B1 (de)
FR2729828B1 (de)
ECSDI950223S (de)
IN184060B (de)
IN187751B (de)
IN182955B (de)
ECSDI950233S (de)
IN183570B (de)
IN183608B (de)
ECSDI950231S (de)
ECSDI950230S (de)
ECSDI950229S (de)
IN186104B (de)
IN184024B (de)